Product: Valsartan Tablets USP 40 mg, 30 count bottles, Rx only,  Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-570-30
Reason for recall: GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
Recall initiated: 20181231
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated